Genotoxicity of escherichia coli nissle 1917 strain cannot be dissociated from its probiotic activity

Gut Microbes

Volumn 3, Issue 6, 2012, Pages 501-509

  Olier, Maïwenn ^a,b,c,d,e   Marcq, Ingrid ^b,c,d,e   Salvador Cartier, Christel ^a   Secher, Thomas ^b,c,d,e   Dobrindt, Ulrich ^f   Boury, Michèle ^b,c,d,e   Bacquié, Valérie ^a   Penary, Marie ^b,c,d,e   Gaultier, Eric ^a   Nougayrède, Jean Philippe ^b,c,d,e   Fioramonti, Jean ^a   Oswald, Eric ^b,c,d,e,g  

^a TOXALIM RESEARCH CENTRE IN FOOD TOXICOLOGY   (France)

^b CEMAGREF   (France)

^c INSERM   (France)

^d CNRS   (France)

^e UNIVERSITÉ PAUL SABATIER   (France)

^f UNIVERSITY OF MÜNSTER   (Germany)

^g CHU PURPAN   (France)

Author keywords

Cd4 cd45rbhighT cell transfer model; Colibactin; Colitis; Dss; Escherichia coli; Genotoxin; Inflammation; Probiotic

Indexed keywords

MUTAFLOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; CHROMOSOME DAMAGE; CLBA GENE; COLITIS; CONTROLLED STUDY; DISEASE SEVERITY; DNA DAMAGE; EPITHELIUM CELL; ESCHERICHIA COLI; GENE INACTIVATION; GENOMICS; GENOTOXICITY; IMMUNOMODULATION; MICROBIAL ACTIVITY; NONHUMAN; RAT; TREATMENT RESPONSE;

ANIMALS; CELL LINE; COLITIS; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; ESCHERICHIA COLI; GENE KNOCKOUT TECHNIQUES; INFLAMMATORY BOWEL DISEASES; MALE; MUTAGENS; POLYKETIDES; PROBIOTICS; RATS; RATS, WISTAR;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; ESCHERICHIA COLI NISSLE 1917; EUKARYOTA; RATTUS; RODENTIA;

EID: 84868607652     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.4161/gmic.21737     Document Type: Article

References (40)

1. FAO/WHO. Food and Agricultural Organization / World Health Organization. Report -Health and Nutritional Properties of Probiotics in Food Including PowderMilk with Live Lactic Acid Bacteria. Cordoba, Argentina 2001.
2. Sanders ME, Levy DD. The science and regulations of probiotic food and supplement product labeling. Ann N Y Acad Sci 2011; 1219(Suppl 1):E1-23. PMID:21332758; http://dx.doi.org/10.1111/j.1749-6632.2010.05956.x.
3. Gareau MG, Sherman PM, Walker WA. Probiotics and the gut microbiota in intestinal health and disease. Nat Rev Gastroenterol Hepatol 2010; 7:503-14. PMID:20664519; http://dx.doi.org/10.1038/nrgastro.2010.117.
4. Seksik P, Dray X, Sokol H, Marteau P. Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease? Mol Nutr Food Res 2008; 52:906-12. PMID:18384087; http://dx.doi.org/10.1002/mnfr.200700147.
5. Wallace TC, Guarner F, Madsen K, Cabana MD, Gibson G, Hentges E, et al. Human gut microbiota and its relationship to health and disease. Nutr Rev 2011; 69:392-403. PMID:21729093; http://dx.doi.org/10.1111/j.1753-4887.2011.00402.x.
6. Mazmanian SK, Round JL, Kasper DL. A microbial symbiosis factor prevents intestinal inflammatory disease. Nat re 2008; 453:620-5. PMID:18509436; http://dx.doi.org/10.1038/nature07008.
7. Mohamadzadeh M, Pfeiler EA, Brown JB, Zadeh M, Gramarossa M, Managlia E, et al. Regulation of induced colonic inflammation by Lactobacillus acidophilus deficient in lipoteichoic acid. Proc Natl Acad Sci U S A 2011; 108(Suppl 1):4623-30. PMID:21282652; http://dx.doi.org/10.1073/pnas.1005066107.
8. Yan F, Cao H, Cover TL, Washington MK, Shi Y, Liu L, et al. Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism. J Clin Invest 2011; 121:2242-53. PMID:21606592; http://dx.doi.org/10.1172/JCI44031.
9. von Schillde MA, Hörmannsperger G, Weiher M, Alpert CA, Hahne H, Bäuerl C, et al. Lactocepin secreted by Lactobacillus exerts anti-inflammatory effects by selectively degrading proinflammatory chemokines. Cell Host Microbe 2012; 11:387-96. PMID:22520466; http://dx.doi.org/10.1016/j. chom.2012.02.006.
10. Sanders ME, Akkermans LM, Haller D, Hammerman C, Heimbach J, Hörmannsperger G, et al. Safety assessment of probiotics for human use. Gut Microbes 2010; 1:164-85. PMID:21327023; http://dx.doi. org/10.4161/gmic.1.3.12127.
11. Schultz M. Clinical use of E. coli Nissle 1917 in inflammatory bowel disease. Inflamm Bowel Dis 2008; 14:1012-8. PMID:18240278; http://dx.doi. org/10.1002/ibd.20377.
12. Yan F, Polk DB. Probiotics: progress toward novel therapies for intestinal diseases. Curr Opin Gastroenterol 2010; 26:95-101. PMID:19952741; http://dx.doi. org/10.1097/MOG.0b013e328335239a.
13. Kruis W, Fric P, Pokrotnieks J, Lukás M, Fixa B, Kascák M, et al. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 2004; 53:1617-23. PMID:15479682; http://dx.doi.org/10.1136/gut.2003.037747.
14. Kruis W, Schütz E, Fric P, Fixa B, Judmaier G, Stolte M. Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 1997; 11:853-8. PMID:9354192; http://dx.doi.org/10.1046/j.1365-2036.1997.00225.x.
15. Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon AT. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 1999; 354:635-9. PMID:10466665; http://dx.doi.org/10.1016/S0140- 6736(98)06343-0.
16. Grozdanov L, Raasch C, Schulze J, Sonnenborn U, Gottschalk G, Hacker J, et al. Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917. J Bacteriol 2004; 186:5432-41. PMID:15292145; http://dx.doi.org/10.1128/ JB.186.16.5432-5441.2004.
17. Grozdanov L, Zähringer U, Blum-Oehler G, Brade L, Henne A, Knirel YA, et al. A single nucleotide exchange in the wzy gene is responsible for the semirough O6 lipopolysaccharide phenotype and serum sensitivity of Escherichia coli strain Nissle 1917. J Bacteriol 2002; 184:5912-25. PMID:12374825; http://dx.doi.org/10.1128/JB.184.21.5912-5925.2002.
18. Nougayrède JP, Homburg S, Taieb F, Boury M, Brzuszkiewicz E, Gottschalk G, et al. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science 2006; 313:848-51. PMID:16902142; http://dx.doi.org/10.1126/science.1127059.
19. Cuevas-Ramos G, Petit CR, Marcq I, Boury M, Oswald E, Nougayrède JP. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc Natl Acad Sci U S A 2010; 107:11537-42. PMID:20534522; http://dx.doi.org/10.1073/pnas.1001261107.
20. Grabig A, Paclik D, Guzy C, Dankof A, Baumgart DC, Erckenbrecht J, et al. Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor2- and toll-like receptor 4-dependent pathways. Infect Immun 2006; 74:4075-82. PMID:16790781; http://dx.doi.org/10.1128/IAI.01449-05.
21. Kamada N, Inoue N, Hisamatsu T, Okamoto S, Matsuoka K, Sato T, et al. Nonpathogenic Escherichia coli strain Nissle1917 prevents murine acute and chronic colitis. Inflamm Bowel Dis 2005; 11:455-63. PMID:15867585; http://dx.doi.org/10.1097/01. MIB.0000158158.55955.de.
22. Schultz M, Strauch UG, Linde HJ, Watzl S, Obermeier F, Göttl C, et al. Preventive effects of Escherichia coli strain Nissle 1917 on acute and chronic intestinal inflammation in two different murine models of colitis. Clin Diagn Lab Immunol 2004; 11:372-8. PMID:15013990.
23. Ukena SN, Singh A, Dringenberg U, Engelhardt R, Seidler U, Hansen W, et al. Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity. PLoS One 2007; 2:e1308. PMID:18074031; http://dx.doi.org/10.1371/journal.pone.0001308.
24. Velayos FS, Terdiman JP, Walsh JM. Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies. Am J Gastroenterol 2005; 100:1345-53. PMID:15929768; http://dx.doi.org/10.1111/j.1572-0241.2005.41442.x.
25. Cerf-Bensussan N, Gaboriau-Routhiau V. The immune system and the gut microbiota: friends or foes? Nat Rev Immunol 2010; 10:735-44. PMID:20865020; http://dx.doi.org/10.1038/nri2850.
26. Nell S, Suerbaum S, Josenhans C. The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models. Nat Rev Microbiol 2010; 8:564-77. PMID:20622892; http://dx.doi.org/10.1038/nrmicro2403.
27. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008; 134:577-94. PMID:18242222; http://dx.doi.org/10.1053/j.gastro.2007.11.059.
28. Garrett WS, Gallini CA, Yatsunenko T, Michaud M, DuBois A, Delaney ML, et al. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe 2010; 8:292-300. PMID:20833380; http://dx.doi.org/10.1016/j.chom.2010.08.004.
29. Lupp C, Robertson ML, Wickham ME, Sekirov I, Champion OL, Gaynor EC, et al. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2007; 2:204. PMID:18030708; http://dx.doi.org/10.1016/j.chom.2007.08.002.
30. Lee IA, Bae EA, Hyun YJ, Kim DH. Dextran sulfate sodium and 2,4,6-trinitrobenzene sulfonic acid induce lipid peroxidation by the proliferation of intestinal gram-negative bacteria in mice. J Inflamm (Lond) 2010; 7:7. PMID:20181058; http://dx.doi.org/10.1186/1476-9255-7-7.
31. Carvalho FA, Barnich N, Sauvanet P, Darcha C, Gelot A, Darfeuille-Michaud A. Crohn's disease-associated Escherichia coli LF82 aggravates colitis in injured mouse colon via signaling by flagellin. Inflamm Bowel Dis 2008; 14:1051-60. PMID:18338780; http:// dx.doi.org/10.1002/ibd.20423.
32. Darfeuille-Michaud A, Neut C, Barnich N, Lederman E, Di Martino P, Desreumaux P, et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 1998; 115:1405-13. PMID:9834268; http://dx.doi. org/10.1016/S0016 5085(98)70019-8.
33. Kim SC, Tonkonogy SL, Karrasch T, Jobin C, Sartor RB. Dual-association of gnotobiotic IL-10-/- mice with 2 nonpathogenic commensal bacteria induces aggressive pancolitis. Inflamm Bowel Dis 2007; 13:1457-66. PMID:17763473; http://dx.doi.org/10.1002/ ibd.20246.
34. Waidmann M, Bechtold O, Frick JS, Lehr HA, Schubert S, Dobrindt U, et al. Bacteroides vulgatus protects against Escherichia coli-induced colitis in gnotobiotic interleukin-2-deficient mice. Gastroenterology 2003; 125:162-77. PMID:12851881; http://dx.doi.org/10.1016/S0016-5085(03)00672-3.
35. Azaïs-Braesco V, Bresson JL, Guarner F, Corthier G. Not all lactic acid bacteria are probiotics,.but some are. Br J Nutr 2010; 103:1079-81. PMID:20230653; http://dx.doi.org/10.1017/S0007114510000723.
36. Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 2000; 97:6640-5. PMID:10829079; http://dx.doi.org/10.1073/pnas.120163297.
37. Houdeau E, Moriez R, Leveque M, Salvador-Cartier C, Waget A, Leng L, et al. Sex steroid regulation of macrophage migration inhibitory factor in normal and inflamed colon in the female rat. Gastroenterology 2007; 132:982-93. PMID:17324399; http://dx.doi.org/10.1053/j.gastro.2006.12.028.
38. Morrissey PJ, Charrier K, Braddy S, Liggitt D, Watson JD. CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells. J Exp Med 1993; 178:237-44. PMID:8100269; http://dx.doi.org/10.1084/jem.178.1.237.
39. Powrie F, Leach MW, Mauze S, Caddle LB, Coffman RL. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int Immunol 1993; 5:1461-71. PMID:7903159; http://dx.doi.org/10.1093/intimm/5.11.1461.
40. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 1998; 273:5858-68. PMID:9488723; http://dx.doi. org/10.1074/jbc.273.10.5858.